↓ Skip to main content

A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing

Overview of attention for article published in Frontiers in Pharmacology, July 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
2 news outlets
twitter
1 X user

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
48 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A Novel Anti-Cancer Therapy: CRISPR/Cas9 Gene Editing
Published in
Frontiers in Pharmacology, July 2022
DOI 10.3389/fphar.2022.939090
Pubmed ID
Authors

Xin-Zhu Chen, Rong Guo, Cong Zhao, Jing Xu, Hang Song, Hua Yu, Christian Pilarsky, Firzan Nainu, Jing-Quan Li, Xin-Ke Zhou, Jian-Ye Zhang

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 48 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 8%
Researcher 3 6%
Student > Bachelor 2 4%
Student > Ph. D. Student 2 4%
Other 1 2%
Other 1 2%
Unknown 35 73%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 4 8%
Chemistry 2 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 2%
Chemical Engineering 1 2%
Neuroscience 1 2%
Other 3 6%
Unknown 36 75%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 17. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 January 2024.
All research outputs
#2,067,619
of 25,260,058 outputs
Outputs from Frontiers in Pharmacology
#848
of 19,472 outputs
Outputs of similar age
#43,722
of 427,160 outputs
Outputs of similar age from Frontiers in Pharmacology
#30
of 1,308 outputs
Altmetric has tracked 25,260,058 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 19,472 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 427,160 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 1,308 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.